SANGAMO THERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $52.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $52.20M, a 224.22% increase from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $16.10M, a 67.54% decline from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $49.60M, a 18.10% increase from fiscal 2022.
- SANGAMO THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $42.00M, a 7.69% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $52.20M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $16.10M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $49.60M 10-K · filed 2025-03-17 | |
| 2022-12-31 | $42.00M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $45.50M 10-K · filed 2024-03-13 | |
| 2020-12-31 | $26.60M 10-K · filed 2023-02-23 | |
| 2019-12-31 | $29.60M 10-K · filed 2022-02-24 | -$29.60M 10-K · filed 2020-02-28 |
| 2018-12-31 | $45.30M 10-K · filed 2021-02-24 | |
| 2017-12-31 | -$28.90M 10-K · filed 2020-02-28 | |
| 2016-12-31 | $23.80M 10-K · filed 2019-03-01 | |
| 2015-12-31 | $5.00M 10-K · filed 2018-03-01 | |
| 2014-12-31 | $9.80M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $14.90M 10-K · filed 2016-02-18 | |
| 2012-12-31 | $5.40M 10-K · filed 2015-02-25 | |
| 2011-12-31 | $19.70M 10-K · filed 2014-02-24 | |
| 2010-12-31 | $7.40M 10-K · filed 2013-02-26 |